Miloslavsky, E M <br/><br/>
Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.  [electronic resource] 

 -  Arthritis & rheumatology (Hoboken, N.J.)  Jun 2015 
 - 1629-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2326-5205 
<br/><br/><label>Standard No.: </label>10.1002/art.39104  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis--drug therapy<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Autoantibodies--immunology<br/>Azathioprine--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Glucocorticoids--therapeutic use<br/>Granulomatosis with Polyangiitis--drug therapy<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Maintenance Chemotherapy<br/>Male<br/>Microscopic Polyangiitis--drug therapy<br/>Myeloblastin--immunology<br/>Peroxidase--immunology<br/>Prednisone--therapeutic use<br/>Recurrence<br/>Remission Induction<br/>Rituximab<br/>Severity of Illness Index<br/>Treatment Outcome